| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 1.6 | 1.2 | 1.4 |
| Other income | 0.1 | 0.1 | 0.2 |
| Total income | 1.7 | 1.4 | 1.5 |
| Profit before exceptional items & tax | 0.2 | 0.1 | 0.2 |
| Exceptional items | 0.0 | 2.8 | 0.0 |
| Profit before tax | 0.2 | 2.9 | 0.2 |
| Net profit | 0.1 | 2.4 | 0.1 |
| Operating margin | 11.8% | 207.1% | 13.3% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +0.00% |
|---|---|
| Net profit, quarter on quarter | -95.80% |
| Revenue, year on year | +14.30% |
BSE results filing, NSE: COLINZ. Figures extracted from the filing.
Colinz Laboratories Ltd: key numbers
- Share price
- ₹70.00
- Market cap
- ₹17.63 Cr
- Revenue (annual)
- ₹6.14 Cr
- Net profit (annual)
- ₹0.51 Cr
- P/E (TTM)
- 6.3×Sector 46.1×
- Promoter holding
- 50.60%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Colinz Laboratories Ltd
All →Colinz Laboratories Board Meeting Date
Colinz Laboratories scheduled a board meeting for October 29, 2026, to consider and approve the unaudited financial results for the quarter ended September 30, 2026.
Colinz Laboratories Other Announcement
The company filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Colinz Laboratories Other Announcement
Colinz Laboratories Ltd submitted a non-applicability declaration for Related Party Transaction disclosures for the quarter ended September 30, 2026. The company claims exemption under Regulation 15(2).
Colinz Laboratories Annual General Meeting
Colinz Laboratories held its 40th Annual General Meeting on September 22, 2026, where shareholders considered financial statements and director appointments.
Colinz Laboratories Open Offer: ₹3.54 Cr
Colinz Laboratories Ltd issued a Post Offer Advertisement for an Open Offer. The offer closed with only 6 shares tendered out of a proposed 6,54,966 shares.
- Value
- ₹3.54 Cr
Colinz Laboratories Annual Report
Colinz Laboratories Limited has submitted its 40th Annual Report for the financial year 2025-26. The report includes notice for the Annual General Meeting scheduled for September 22, 2026.